Better understanding of the APN paradox, so unique a phenomenon of APN action in AD, can help us to find a novel therapeutic strategy that is distinct from previous therapy for AD and find a useful biomarker for evaluating AD progression. The gene discussed is ANPEP; the disease is Alzheimer disease.